Aufzeichnung CFWebinar: EPO Case Law Update 2024/2025 - Chemistry, Pharma and Life Sciences
The topics to be discussed are:
- Enlarged Board of Appeal Referrals
- G1/24 “Heated aerosol” on using the description to interpret the claims
- G 1/23 “Solar cell” on commercially available (but not necessarily reproducible) compositions as prior art
- EPO Case Law covering both procedural as well as substantive issues, including sufficiency of disclosure, added matter, novelty, and inventive step
- Tips on strategic aspects based on recent EPO opposition and appeal cases
Speaker
Verwandte Nachrichten
A&O SHEARMAN and COHAUSZ & FLORACK successful for Bayer in keeping generics off the German market
Higher Regional Court Munich upholds preliminary injunctions based on Bayer’s patent on the once-daily administration of rivaroxaban (Xarelto®)
Mehr erfahren
Kontextgebundene Auslegung von Patentansprüchen
BGH-Urteil „Stereofotogrammetrie“ – X ZR 88/22
Mehr erfahren
8 Facts Every Patent Owner Should Know About Germany as a Patent Monetization Powerhouse
Patents are key to protecting innovation and driving company profits. Let’s explore why Germany and the EU are global leaders when it comes to patent monetization!
Mehr erfahren
